See also this year's filing and all EDGAR filings for this company.
PDF Report 0001267813_2024_Marinus_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 1.7245472129417971, 'aggregate_val': 30989000, 'exp_sum': 11374000, 'exp_to_value': {'remainder_Revenues': 11374000}} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 15, '00205 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOS) - Calc2': 2}} |
Graph
Absolute values for 0001267813, Marinus Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 165,246,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,843,000 |
| 3 | remainder_Assets | 1,819,000 |
| 4 | LiabilitiesCurrent | 40,624,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 113,519,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 64,732,567 |
| 9 | ResearchAndDevelopmentExpense | 101,774,203 |
| 10 | remainder_Expenses | 18,054,034 |
| 11 | remainder_Revenues | 39,297,389 |
| 12 | remainder_NetIncome | 54,372,599 |
| 13 | remainder_ComprehensiveNetIncome | -20,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 170,908,000 |
| 1 | Liabilities | 154,143,000 |
| 2 | Expenses | 184,560,804 |
| 3 | Revenues | 39,297,389 |
| 4 | StockholdersEquity | 16,765,000 |
| 5 | NetIncome | -90,890,816 |
| 6 | ComprehensiveNetIncome | -90,900,816 |
| 7 | BaseVar | 301,650,896 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.334 |
| 9 | EconomicCapitalRatio | 1.40 |